openPR Logo
Press release

Global Companion Diagnostic Tests in Oncology Market to Rise at an Impressive CAGR of 16.8% during the Forecast Period of 2017 – 2025:MRRSE

07-17-2017 11:28 AM CET | Health & Medicine

Press release from: Latest Research Reports Trends  - MRRSE

MRRSE

MRRSE

The global companion diagnostic tests in oncology market is anticipated to display phenomenal growth due to rising adoption of new tests, and shift from blockbuster drugs to personalized drugs and targeted therapies. Rising prevalence of cancer, increasing financial burden of cancer treatment, and increasing mortalities due to cancer are some of the major reasons for increasing demand for new and advanced treatment options, cures, and drugs for the treatment of cancer. A new research report with a title “Companion Diagnostic Tests in Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025” has been recently added to the vast online repository of Market Research Reports Search Engine (MRRSE). The report on companion diagnostic tests in oncology market is an in-depth and professional analysis of the current situation as well as its future potential.

Request for Sample Report: http://www.mrrse.com/sample/3096

According to this research report, the global companion diagnostic tests in oncology market is likely to grow at a CAGR of 16.8% during the period of 2017 - 2025. At this pace, the market will reach a valuation of US$13.6 billion by the end of 2025 from US$3.5 billion in 2016. The market overview section of the report includes a qualitative analysis of the overall companion diagnostic tests in oncology market considering the aspects determining the market dynamics such as drivers, restraints, risks and opportunities, along with Porter’s five force analysis and market attractiveness analysis. Besides this, market opportunity analysis for biomarker, detection techniques, and type of cancer and major industry developments has also been provided in the report.

The global companion diagnostic tests in oncology market is segregated on the basis of detection technique, biomarker, cancer type, and end-user. The market size and forecast in terms of revenue (US$ Million) for each of these segments are provided for the period 2015 to 2025, taking 2016 as the base year. It also provides a CAGR for each segment during the forecast period 2017 to 2025. Geographically, the companion diagnostic tests in oncology market is segmented into five major regions namely Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.

The report also provides a section on the competitive landscape analysis, in which the market share analysis of top players in the global companion diagnostic tests in oncology market, in terms of percentage share in 2016 are precisely discussed. Finally, the report concludes with the profiles of key players in the global Companion Diagnostic Tests in Oncology market such as QIAGEN, Illumina, Inc., Abbott, Agilent Technologies, Inc., Genomic Health, Inc., F. Hoffman LA Roche Ltd., bioMerieux SA, BioGenex, Siemens Healthcare GmBH, AGENDIA NV, and Thermo Fisher Scientific, Inc., among others. The major market players are assessed on key parameters such as company overview, financial strategies, financial overview, product portfolio, business strategies and recent developments.

Browse Full Report with TOC: http://www.mrrse.com/companion-diagnostic-tests-market

 About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Follow Us on LinkedIn-https://www.linkedin.com/company/mrrse
Follow Us On Twitter-https://twitter.com/MRRSEmrrse

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Companion Diagnostic Tests in Oncology Market to Rise at an Impressive CAGR of 16.8% during the Forecast Period of 2017 – 2025:MRRSE here

News-ID: 626742 • Views:

More Releases from Latest Research Reports Trends  - MRRSE

FastMed Urgent Care, MD Now, MinuteClinic LLC, MedExpress, NextCare Urgent Care, Patient First and U.S. HealthWorks are some of the key players in Urgent Care Centers Market
FastMed Urgent Care, MD Now, MinuteClinic LLC, MedExpress, NextCare Urgent Care, …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Urgent Care Centers Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. Get Report Sample Copy for Market Insights @ https://www.mrrse.com/sample/980 This report on urgent care
Wheelchair Accessible Vehicle Converters Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Wheelchair Accessible Vehicle Converters Market - North America Industry Analysi …
This report on the North America wheelchair accessible vehicle converters market analyzes the current and future prospects of the market. It comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. It is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research
Farm Tractor Market - North America and Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Farm Tractor Market - North America and Europe Industry Analysis, Size, Share, G …
This report on the North America and Europe Farm Tractor market provides analysis for the period 2014–2024, wherein 2015 is the base year and the period from 2016 to 2024 is the forecast period. Data for 2014 has been included as historical information. The report covers all the prevalent trends and technologies playing a vital role in the growth of the farm tractor market over the forecast period in both
Theater Linen Market for Health Care Application - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Theater Linen Market for Health Care Application - Global Industry Analysis, Siz …
The report estimates and forecasts the Theater Linen Market for healthcare application on the global, regional, and country level. The study provides forecast between 2016 and 2024 based on revenue (US$ Mn) with 2015 as the base year. The report comprises an exhaustive value chain analysis for each of the material segments. It provides comprehensive view of the market. Value chain analysis also offers detailed information about value addition at

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion